Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.02 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 509 | 0.91 |
| pathways Reactome | 3 pathways; mostly iron and oxidative stress | 0.80 |
No case: the score is under the bar. Receipt 7415
Sealed predictions
- KDM6B in dopamine neurons, braak-0.41 (p 0.269) → -0.39 (p 0.297)receipt 7422
Swarm cases
receipt 7422: KDM6B in dopamine neurons, braak
- power
- full sample -0.42 (p 0.084, n 18), 95% CI -0.74 to +0.06. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.42 (p 0.084, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.53 (p 0.022, n 18). not the mix.
- skeptic
- leave-one-out range -0.60 to -0.34, sign flips 0; without severely affected donors -0.42 (p 0.084, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KDM6B in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts